TECHNOLOGY AND DATA MANAGEMENT


What’s more, while the immutable nature of the blockchain is touted as proof of its security, this unique feature could cause serious problems both for patients and for the parties purchasing the health data. If we are unable to erase or modify data stored on the blockchain, any errors or inaccuracies in a person’s health  compromising both the medical research and patient care that rely on that data. The blockchain’s immutability is also at odds with the European Union’s General Data Protection     There’s also no escaping the fact that NFT technology is complicated. How can we  information when, at this stage, NFTs are  understand? The Science commentary points  intermediaries to help mint and manage their NFTs, “socioeconomic factors will act as gatekeepers for digital ledger citizenship”  participation gaps”. Kaldasch admits that accessibility to NFTs is a problem but says companies in the space are working to change this, and he’s optimistic  “It’s good to be in [this space] early, to adapt the technology, grow with it, and support the mission to make this more accessible,” he says. Last but certainly not least, NFTs are currently


  transaction, and mining the cryptocurrencies   the technology, and the solutions and   crisis. The pharma industry, which is already facing pressure to reduce its carbon footprint, should be particularly cautious when it comes 


The future of patient data?  there is a lot that must (and possibly may


46 | Outsourcing in Clinical Trials Handbook


“What’s more, the immutable nature of the blockchain could cause serious problems both for patients and for the parties purchasing the health data. If we are unable to erase or modify data stored on the blockchain, any errors or inaccuracies in a person’s health information cannot 


   NFT technology is already being employed in hospital projects and clinical trials, and Nasr  pharma company about applications for the company’s software. 


NFTs is accountability and patient control;  widespread in health research and care,  “It would be really great for all parties


     one direction.”


Page 1  |  Page 2  |  Page 3  |  Page 4  |  Page 5  |  Page 6  |  Page 7  |  Page 8  |  Page 9  |  Page 10  |  Page 11  |  Page 12  |  Page 13  |  Page 14  |  Page 15  |  Page 16  |  Page 17  |  Page 18  |  Page 19  |  Page 20  |  Page 21  |  Page 22  |  Page 23  |  Page 24  |  Page 25  |  Page 26  |  Page 27  |  Page 28  |  Page 29  |  Page 30  |  Page 31  |  Page 32  |  Page 33  |  Page 34  |  Page 35  |  Page 36  |  Page 37  |  Page 38  |  Page 39  |  Page 40  |  Page 41  |  Page 42  |  Page 43  |  Page 44  |  Page 45  |  Page 46  |  Page 47  |  Page 48  |  Page 49  |  Page 50  |  Page 51  |  Page 52  |  Page 53  |  Page 54  |  Page 55  |  Page 56  |  Page 57  |  Page 58  |  Page 59  |  Page 60  |  Page 61  |  Page 62  |  Page 63  |  Page 64  |  Page 65  |  Page 66  |  Page 67  |  Page 68  |  Page 69  |  Page 70  |  Page 71  |  Page 72  |  Page 73  |  Page 74  |  Page 75  |  Page 76  |  Page 77  |  Page 78  |  Page 79  |  Page 80  |  Page 81  |  Page 82  |  Page 83  |  Page 84  |  Page 85  |  Page 86  |  Page 87  |  Page 88  |  Page 89  |  Page 90  |  Page 91  |  Page 92  |  Page 93  |  Page 94  |  Page 95  |  Page 96  |  Page 97  |  Page 98  |  Page 99  |  Page 100